FRC
FRC Logo
Sign InGet Access

Connect With Us

Stay updated with our latest research and insights

Fundamental Research Corp Logo

Highly ranked equity research firm providing institutional grade tools and analysis to all investors worldwide. Trusted by global investors for over 20+ years.

20+ Years

Policies

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Company

  • About Us
  • Our Team
  • Contact Us

Resources

  • Videos
  • Research Reports
  • FAQ

© 2026 Fundamental Research Corp. All Rights Reserved.

Professional investment research since 2003

Home
Research
Get Access
Sign In
Anew Medical, Inc. Stock AnalysisComprehensive stock analysis for Anew Medical, Inc. (WENAW) including live price, Snowflake performance metrics, financial statements, and investment research.Stock AnalysisWENAW
WENAW
Anew Medical, Inc.
  • Company Overview
  • FRC Research
  • Financial Data
  • Peer Comparison
  • Ownership & News
WENAW
Home🔹Stocks🔹Anew Medical, Inc.

Anew Medical, Inc.

WENAW•NASDAQ

Anew Medical, Inc.

WENAW•NASDAQ
Market cap
$681.44K
Sentiment

Your view on WENAW

Mkt Cap
$681.44K
Sentiment
Your view
WENAW
Anew Medical, Inc.
  • Company Overview
  • FRC Research
  • Financial Data
  • Peer Comparison
  • Ownership & News
WENAW
Company Overview

Overview

What the company does, where it operates, and who runs it.

About Anew Medical, Inc.

Industry
Biotechnology
Sector
Healthcare
CEO
Joseph Sinkule
Headquarters
13576 Walnut Street, Omaha, NE, US
Industry
Biotechnology
Sector
Healthcare
CEO
Joseph Sinkule
Headquarters
13576 Walnut Street, Omaha, NE, US
Description

Anew Medical, Inc., a biopharmaceutical enterprise, is dedicated to pioneering advanced therapies for neurological and age-related disorders, alongside developing specialized diagnostic tools. The company's diverse portfolio encompasses cutting-edge cell and gene therapies, specifically designed to mitigate the progression of age-related pathologies, including symptoms of dementia, Alzheimer's disease, and various neuromuscular conditions. Anew Medical also develops biologics and biosimilars for the treatment of cancer, and conducts research into melanocortin receptor systems. Further demonstrating its commitment to innovative solutions, Anew Medical has established a significant strategic alliance with Japan's Okinawa Research Center. This collaboration is centered on the research and development of Klotho gene therapy, with the ambitious goal of enhancing human longevity and diminishing the prevalence of age-related illnesses. Anew Medical, Inc. maintains its headquarters in Omaha, Nebraska.

FRC Research

Media

Infographics, videos, and posts covering the company.

Financial Data

Stock Data

Price chart, volume, and trading data.

Fair Value

What FRC thinks the stock is worth vs. the current price.

FRC's fair value estimate for Anew Medical, Inc., and the rating behind it. FRC analysts run the firm's valuation model across the companies on this platform to estimate what each one is worth, rather than republishing a consensus average. Shows the current estimate, our rating, and when it was last revised. A free account covers 7 company valuations a month; a paid subscription is unlimited.

Financial Ratios

Profitability, returns, valuation, and leverage ratios.

Valuation, profitability, liquidity and leverage ratios for Anew Medical, Inc.. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.

Dividend Analysis

Yield, payout ratio, and dividend coverage metrics.

Dividend history, yield and payout sustainability for Anew Medical, Inc.. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.

Earnings Analysis

EPS history, beat rate, and upcoming earnings reports.

Reported vs. expected earnings history for Anew Medical, Inc.. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.

Financial Statements

Income statement, balance sheet, and cash flow statements.

Income statement, balance sheet and cash flow history for Anew Medical, Inc.. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.

Peer Comparison

Comparables

List of peer companies in the same industry.

Anew Medical, Inc. valued side by side against its closest peers. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.

Ownership & News

Institutional Ownership

Which funds and firms own the stock.

Which institutions hold Anew Medical, Inc., and how their positions are changing. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings.

Insider Trading

Recent buying and selling by company executives.

Buying and selling by Anew Medical, Inc. executives and directors. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned.

Senate Trading

U.S. Senator disclosures filed under the STOCK Act.

U.S. Senate disclosures naming Anew Medical, Inc.. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely.

House Trading

U.S. Representative disclosures filed under the STOCK Act.

U.S. House of Representatives disclosures naming Anew Medical, Inc.. Representatives' reported transactions in this security, shown next to the company's fundamentals.

News

Latest headlines and market coverage.

Latest headlines and company announcements for Anew Medical, Inc.. Press releases and market coverage, newest first.

News

Latest Market News